BR112016024756A2 - regimes de dosagem de nitisinona para o tratamento da alcaptonúria - Google Patents
regimes de dosagem de nitisinona para o tratamento da alcaptonúriaInfo
- Publication number
- BR112016024756A2 BR112016024756A2 BR112016024756A BR112016024756A BR112016024756A2 BR 112016024756 A2 BR112016024756 A2 BR 112016024756A2 BR 112016024756 A BR112016024756 A BR 112016024756A BR 112016024756 A BR112016024756 A BR 112016024756A BR 112016024756 A2 BR112016024756 A2 BR 112016024756A2
- Authority
- BR
- Brazil
- Prior art keywords
- nitisinone
- alcaptonuria
- treatment
- dosing regimens
- administered
- Prior art date
Links
- OUBCNLGXQFSTLU-UHFFFAOYSA-N nitisinone Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1C(=O)CCCC1=O OUBCNLGXQFSTLU-UHFFFAOYSA-N 0.000 title abstract 6
- 229960001721 nitisinone Drugs 0.000 title abstract 5
- 206010001689 alkaptonuria Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1450521 | 2014-04-30 | ||
| PCT/EP2015/059352 WO2015165972A1 (en) | 2014-04-30 | 2015-04-29 | Nitisinone dosing regimens for the treatment of alkaptonuria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016024756A2 true BR112016024756A2 (pt) | 2017-08-15 |
Family
ID=53175441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016024756A BR112016024756A2 (pt) | 2014-04-30 | 2015-04-29 | regimes de dosagem de nitisinona para o tratamento da alcaptonúria |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170049716A1 (enExample) |
| EP (1) | EP3137066A1 (enExample) |
| JP (1) | JP2017514820A (enExample) |
| AU (1) | AU2015254669A1 (enExample) |
| BR (1) | BR112016024756A2 (enExample) |
| CA (1) | CA2947062A1 (enExample) |
| IL (1) | IL248506A0 (enExample) |
| MA (1) | MA39918A (enExample) |
| SG (1) | SG11201608957VA (enExample) |
| TN (1) | TN2016000479A1 (enExample) |
| WO (1) | WO2015165972A1 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2838039C (en) * | 2011-06-23 | 2017-10-24 | Swedish Orphan Biovitrum International Ab | Liquid pharmaceutical composition comprising nitisinone |
-
2015
- 2015-04-29 WO PCT/EP2015/059352 patent/WO2015165972A1/en not_active Ceased
- 2015-04-29 AU AU2015254669A patent/AU2015254669A1/en not_active Abandoned
- 2015-04-29 BR BR112016024756A patent/BR112016024756A2/pt not_active IP Right Cessation
- 2015-04-29 MA MA039918A patent/MA39918A/fr unknown
- 2015-04-29 JP JP2016564948A patent/JP2017514820A/ja active Pending
- 2015-04-29 EP EP15722113.6A patent/EP3137066A1/en not_active Withdrawn
- 2015-04-29 US US15/307,622 patent/US20170049716A1/en not_active Abandoned
- 2015-04-29 CA CA2947062A patent/CA2947062A1/en not_active Abandoned
- 2015-04-29 SG SG11201608957VA patent/SG11201608957VA/en unknown
- 2015-04-29 TN TN2016000479A patent/TN2016000479A1/en unknown
-
2016
- 2016-10-26 IL IL248506A patent/IL248506A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017514820A (ja) | 2017-06-08 |
| SG11201608957VA (en) | 2016-11-29 |
| MA39918A (fr) | 2017-03-08 |
| EP3137066A1 (en) | 2017-03-08 |
| WO2015165972A1 (en) | 2015-11-05 |
| IL248506A0 (en) | 2016-12-29 |
| AU2015254669A1 (en) | 2016-12-15 |
| US20170049716A1 (en) | 2017-02-23 |
| CA2947062A1 (en) | 2015-11-05 |
| TN2016000479A1 (en) | 2018-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018076601A2 (pt) | formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação | |
| MX2018003388A (es) | Agonistas del receptor farnesoide x y usos de los mismos. | |
| CY1122469T1 (el) | Υπογλωσσια φαρμακοτεχνικη μορφη ριλουζολης | |
| SV2017005426A (es) | Derivados de feniltriazol sustituido con hidroxialquilo y sus usos | |
| CL2019001214A1 (es) | Composición farmacéutica, métodos para tratamiento y sus usos. | |
| EP3222278C0 (en) | Use of azelnidipine in preparing medicinal composition for treating cancers | |
| CL2015002767A1 (es) | Compuestos terapéuticos y composiciones | |
| CR20160537A (es) | Inhibidor de fosfoinosítido 3-quinasa delta para su uso medico | |
| CL2015000744A1 (es) | Combinación de regorafenib y ácido acetilsalicílico para el tratamiento del cáncer. | |
| CL2015002608A1 (es) | Compuesto de amino-pirazol y usos medicinales relacionados. | |
| CR20180253A (es) | Composiciones terapéuticas para el tratamiento del virus de unmunodeficiencia humana | |
| ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
| CL2015001610A1 (es) | Compuestos derivados de pirimido-[4,5-b]-quinolina-4,5(3h,10h)-dionas para utilizarse como un medicamento para el tratamiento de una enfermedad causada por una mutacion sin sentido; composicion y combinacion farmaceutica que los comprende. | |
| CL2017001904A1 (es) | Composición para el tratamiento de enfermedad veno-oclusiva hepática. | |
| BR112016027435A2 (pt) | formulação inovadora de meloxicam | |
| BR112016018685A2 (pt) | regime de dosagem com composto de fgf-18 | |
| BR112018006206A2 (pt) | composição, uso de uma combinação, forma de dosagem fixa farmacêutica, combinação de dosagem fixa, embalagem, e, uso de uma combinação de dose fixa | |
| ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
| BR112017014189A2 (pt) | terapia de câncer com um parvovirus combinado com bevacizumabe | |
| ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
| MX2018000872A (es) | Combinaciones terapeuticas de paclitaxel oralmente administrado y un inhibidor de la bomba de p-glicoproteina (p-gp) para el tratamiento del cancer. | |
| MX2017013633A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas. | |
| CR20170125A (es) | Composición farmacéutica sólica que comprende amlodipina y losartán | |
| CL2018003707A1 (es) | Regímenes de dosificación de vortioxetina para el rápido inicio del efecto antidepresivo. | |
| BR112016024756A2 (pt) | regimes de dosagem de nitisinona para o tratamento da alcaptonúria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2564 DE 2020-02-27 |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |